Cannabis sativa extracts inhibit LDL oxidation and the formation of foam cells in vitro, acting as potential multi-step inhibitors of atherosclerosis development
2024

Cannabis Extracts and Atherosclerosis

publication 10 minutes Evidence: high

Author Information

Author(s): Musetti Bruno, Kun Alejandra, Menchaca David, Rodríguez-Haralambides Alejandra, Varela Javier, Thomson Leonor, Bahnson Edward M.

Primary Institution: Facultad de Ciencias, Instituto de Química Biológica, Universidad de la República, Montevideo, Uruguay

Hypothesis

The study investigates the effect of cannabis sativa extracts on the molecular mechanisms triggering atheromatous lesion development.

Conclusion

Cannabis extracts inhibit LDL oxidation and foam cell formation, suggesting their potential as therapeutic agents in atherosclerosis.

Supporting Evidence

  • The extracts inhibited LDL oxidation by copper ions.
  • Phytocannabinoids reduced the uptake of oxidized LDL by macrophages.
  • The study identified non-canonical receptors involved in the effects of cannabis extracts.
  • Extracts showed antioxidant properties that may contribute to their protective effects.
  • Decreased levels of scavenger receptors were observed after treatment with cannabis extracts.

Takeaway

This study shows that cannabis extracts can help prevent heart disease by stopping bad cholesterol from causing damage in the body.

Methodology

The study used UPLC-DAD for chemical characterization and various assays to monitor LDL oxidation and foam cell formation in J774.1 cells.

Limitations

The study was conducted in a murine macrophage-like model with low CD36 expression, which may not fully represent human atherosclerosis mechanisms.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1371/journal.pone.0310777

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication